case studies

Filter by:
Identifying Barriers to Biomarker Testing Efficiency: 100 Laboratories Mapped in 3 Months

Diaceutics enhances biomarker testing efficiency, engaging over 150 labs to identify workflow barriers, optimize practices, and support timely clinical decision-making for better patient outcomes.

By Peter Keeling
Commercial Strategy Optimization
Driving Strategic Diagnostic Planning for a Targeted Therapy in Gender-specific Cancer

Drive awareness and adoption of precision therapy for gender-specific cancer through strategic diagnostic planning and tailored solutions from Diaceutics. Unlock your therapy's full potential.

Commercial Strategy Optimization
Strategic Diagnostics in Action

Diaceutics accelerated gene therapy access by implementing a global strategy, reducing test result turnaround times from 28 days to 1 week and enhancing patient identification.

Commercial Strategy Optimization
Accelerating HCP Engagement in Myeloid Malignancies Through Real-world Data and Targeted Engagement

Learn how a global pharma company achieved a 7X ROI through leveraging Diaceutics' real-world data and Physician Engage

HCP Engagement & Activation
Turning Biomarker Insight into Clinical Action

Diaceutics accelerated gene therapy access by implementing a global strategy, reducing test result turnaround times from 28 days to 1 week and enhancing patient identification.

HCP Engagement & Activation
Unlocking Diagnostic Clarity to Accelerate Market-Ready Strategy 

Unlock diagnostic clarity to drive market readiness, enhance adoption, and mitigate launch risks with tailored strategies and insights from Diaceutics. Connect to realize your therapy's potential.

Commercial Strategy Optimization
Delivering precision medicine success through a multi-year commercialization partnership

Discover how a global pharmaceutical leader successfully launched a first-in-class oncology therapy through strategic partnerships, accelerating testing readiness and driving adoption in precision medicine.

Commercial Strategy Optimization
Timely Peer Education to Overcome Clinical Hesitation in Rare Oncology

Timely peer education improved HCP engagement and confidence in rare oncology therapy, enhancing diagnostic understanding and accelerating patient access.

HCP Engagement & Activation
Driving Global Diagnostic Accuracy for Biomarker Quantification in a Female-Specific Cancer

Discover how Diaceutics enhanced biomarker quantification accuracy for a new cancer therapy, improving diagnosis and patient identification through global studies and targeted training for pathologists.

Commercial Strategy Optimization
Accelerating HCP Outreach in NSCLC Through Real-Time Biomarker Alerts

Find out how one global pharma company received an 15x increase in HCP engagement for their NSCLC therapy through implementing Signal.

HCP Engagement & Activation
Driving Physician Engagement in a Rare Pediatric Disease Through Real-World Data and Precision Outreach

Discover how Physician Engage helped a top global pharma compnay generate $2 million in revenue for their project.

HCP Engagement & Activation

Stay ahead with the diaceutics newsletter

Diagnostic-driven therapies are reshaping commercialization. Get evidence-based content, expert perspectives, and practical intelligence delivered straight to your inbox, every two weeks.

Ready to do commercialization differently?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find themso more people get the right therapy sooner.